Eli Lilly and Company has announced plans to invest $6.5bn in an active pharmaceutical ingredients (API) manufacturing facility at Generation Park in Houston, in the US state of Texas. The new ...

German CDMO BioSpring is building a new production facility that it hopes will become one of the world's biggest manufacturing sites for DNA- and RNA-based active pharmaceutical ingredients (API). The ...

Eli Lilly has revealed the location of the second of its four large-scale manufacturing facilities that it plans to build in the U.S., selecting Houston as home to a $6.5 billion plant that will ...

The global contract development and manufacturing organization announced March 23 it completed initial engineering studies for an expanded facility in Charles City, Iowa. Groundbreaking for the new ...

Eli Lilly and Company (Lilly) plans to construct an active pharmaceutical ingredient (API) manufacturing facility, totaling around 1 million square feet, in Harris County, Texas. According to news ...

A rendering of the $5 billion manufacturing facility that Eli LIlly plans to build in Virginia's Goochland County near Richmond. The planned manufacturing plant will be the company's first-ever ...